To compare corneal endothelial damage associated with 2 techniques for preloaded Descemet membrane endothelial keratoplasty (DMEK): a tri-folded graft stored in a plastic cartridge designed for DMEK and a scrolled graft stored in a modified Jones Tube, at the time of preparation and after shipping.
DMEK grafts were prepared at the Rocky Mountain Lions Eye Bank. The grafts were either tri-folded and loaded in a plastic cartridge or scrolled and loaded into a modified Jones Tube. In each group, the grafts were then either immediately removed from the cartridges or shipped for 48 hours. The grafts were then stained with Calcein AM and imaged using a fluorescent microscope. Endothelial cell loss (ECL) was determined using trainable segmentation in Fiji by 2 graders. At each time point, rates of ECL loss were compared across the 2 groups. To explore the role of donor characteristics, a multivariable regression model was produced to account for method (tri-folding vs. scroll), donor age, donor gender, death-to-preservation time, death-to-preparation time, and shipping.
A total of 40 grafts were prepared, processed, imaged, and analyzed. No significant difference in cell loss was seen between groups at either time point alone. In the multivariate model, no significant increase in cell loss was associated with either tri-folding (3.7% less ECL; P = 0.051) or shipping (4.3% less ECL; P = 0.049).
All techniques used resulted in clinically acceptable levels of ECL. Tri-folded tissue in a plastic cartridge did not result in ECL inferior to a scroll when prepared either immediately or preloaded for 48 hours.
*Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD;
†Rocky Mountain Lions Eye Bank, Denver, CO; and
‡Wilmer Eye Institute at Johns Hopkins University School of Medicine, Baltimore, MD.
Correspondence: Allen Omid Eghrari, MD, Eye Institute at Johns Hopkins, 1800 Orleans St, Woods 375, Baltimore, MD 21287 (e-mail: firstname.lastname@example.org).
Supported by the Department of Biomedical Engineering and the Center for Bioengineering Innovation and Design at Johns Hopkins University. Additional financial support was provided by the NIH NIBIB DEBUT Prize (E.C., K.B., S.C., C.C., A.S., A.C., A.R., P.V., A.O.E.), Venturewell E-Team (E.C., K.B., S.C., C.C., A.S., A.C., A.R., P.V., A.O.E.), the Research to Prevent Blindness Sybil B. Harrington Special Scholar Award (A.O.E.), and the David and Cynthia Tolsma Fund (A.O.E.). We are grateful to Rocky Mountain Lions Eye Bank which provided tissue and staff support.
The following authors have ownership interest in Treyetech: E.C., K.B., S.C., C.C., A.S., A.O.E.
Received August 07, 2018
Accepted October 30, 2018